The Cefriaxone Injection, cataloged under National Stock Number 6505-01-304-4964, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Baxter Healthcare Corporation. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-304-4964 |
| Primary Part Number | 2G3504 |
| Item Name | Cefriaxone Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Baxter Healthcare Corporation |
| Status | ACTIVE |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BAG, PLASTIC |
| Protective Storage Feature | FROZEN FOR PRESERVATION |
| Active Medicament Medicinal Strength | 1.000 GRAMS CEFTRIAXONE EQUIVALENT G |
| Total Primary Container Quantity | 24 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
NSN 6505-01-304-4964 is a Cefriaxone Injection, manufactured by Baxter Healthcare Corporation, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-304-4964 has 2 manufacturer part numbers on file: 2G3504 (Baxter Healthcare Corporation), 2G3504 (Baxter Healthcare Corporation Div Bioscience).
Key specifications for 2G3504: Primary Container Content Quantity: 50.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BAG, PLASTIC; Special Features: STERILE; NON-PYROGENIC ISO-OSMOTIC SOLUTION WITH 1.9 G DEXTROSE HYDROUS; USP; SINGLE DOSE 50 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT; FOR USE WITH STOCKLISTED INTRAVENOUS INJECTION SETS; FOR INTRAVENOUS INFUSION G. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.